메뉴 건너뛰기




Volumn 52, Issue 1, 2017, Pages 53-58

Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT;

EID: 84983540216     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2016.211     Document Type: Article
Times cited : (50)

References (24)
  • 2
    • 84946706774 scopus 로고    scopus 로고
    • Old medications and new targeted therapies in systemic sclerosis
    • Nagaraja V, Denton CP, Khanna D. Old medications and new targeted therapies in systemic sclerosis. Rheumatology 2015; 54: 1944-1953
    • (2015) Rheumatology , vol.54 , pp. 1944-1953
    • Nagaraja, V.1    Denton, C.P.2    Khanna, D.3
  • 3
    • 84908126065 scopus 로고    scopus 로고
    • Systemic sclerosis evolution of disease pathomorphosis and survival Our experience on Italian patients' population and review of the literature
    • Ferri C, Sebastiani M, Lo Monaco A, Iudici M, Giuggioli D, Furini F et al. Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature. Autoimmun Rev 2014; 13: 1026-1034
    • (2014) Autoimmun Rev , vol.13 , pp. 1026-1034
    • Ferri, C.1    Sebastiani, M.2    Lo Monaco, A.3    Iudici, M.4    Giuggioli, D.5    Furini, F.6
  • 4
    • 66149100618 scopus 로고    scopus 로고
    • EULAR recommendations for the treatment of systemic sclerosis: A report from the EULAR Scleroderma Trials and Research group (EUSTAR)
    • Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L et al. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 2009; 68: 620-628
    • (2009) Ann Rheum Dis , vol.68 , pp. 620-628
    • Kowal-Bielecka, O.1    Landewé, R.2    Avouac, J.3    Chwiesko, S.4    Miniati, I.5    Czirjak, L.6
  • 6
    • 33845643063 scopus 로고    scopus 로고
    • A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
    • Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS et al. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 2006; 54: 3962-3970
    • (2006) Arthritis Rheum , vol.54 , pp. 3962-3970
    • Hoyles, R.K.1    Ellis, R.W.2    Wellsbury, J.3    Lees, B.4    Newlands, P.5    Goh, N.S.6
  • 8
    • 77956955777 scopus 로고    scopus 로고
    • The efficacy of treatment for systemic sclerosis interstitial lung disease: Results from a meta-analysis
    • Broad K, Pope JE. The efficacy of treatment for systemic sclerosis interstitial lung disease: results from a meta-analysis. Med Sci Monit 2010; 16: RA187-RA190
    • (2010) Med Sci Monit , vol.16 , pp. RA187-RA190
    • Broad, K.1    Pope, J.E.2
  • 9
    • 55749093240 scopus 로고    scopus 로고
    • Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: A systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies
    • Nannini C, West CP, Erwin PJ, Matteson EL. Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies. Arthritis Res Ther 2008; 10: R124
    • (2008) Arthritis Res Ther , vol.10 , pp. R124
    • Nannini, C.1    West, C.P.2    Erwin, P.J.3    Matteson, E.L.4
  • 10
    • 84926335197 scopus 로고    scopus 로고
    • Systemic sclerosis: A systematic review on therapeutic management from 2011 to 2014
    • Young A, Khanna D. Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014. Curr Opin Rheumatol 2015; 27: 241-248
    • (2015) Curr Opin Rheumatol , vol.27 , pp. 241-248
    • Young, A.1    Khanna, D.2
  • 11
    • 84875009952 scopus 로고    scopus 로고
    • Update on stem cell transplantation for systemic sclerosis: Recent trial results
    • Naraghi K, van Laar JM. Update on stem cell transplantation for systemic sclerosis: recent trial results. Curr Rheumatol Rep 2013; 15: 326-331
    • (2013) Curr Rheumatol Rep , vol.15 , pp. 326-331
    • Naraghi, K.1    Van Laar, J.M.2
  • 12
    • 80051468836 scopus 로고    scopus 로고
    • Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): An open-label, randomised phase 2 trial
    • Burt RK, Shah SJ, Dill K, Grant T, Gheorghiade M, Schroeder J et al. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet 2011; 378: 498-506
    • (2011) Lancet , vol.378 , pp. 498-506
    • Burt, R.K.1    Shah, S.J.2    Dill, K.3    Grant, T.4    Gheorghiade, M.5    Schroeder, J.6
  • 13
    • 84902844800 scopus 로고    scopus 로고
    • Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: A randomized clinical trial
    • van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J et al. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 2014; 311: 2490-2498
    • (2014) JAMA , vol.311 , pp. 2490-2498
    • Van Laar, J.M.1    Farge, D.2    Sont, J.K.3    Naraghi, K.4    Marjanovic, Z.5    Larghero, J.6
  • 15
    • 0018887574 scopus 로고
    • Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee preliminary criteria for the classification of systemic sclerosis (scleroderma)
    • Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590
    • (1980) Arthritis Rheum , vol.23 , pp. 581-590
  • 16
    • 84886777196 scopus 로고    scopus 로고
    • 2013 classification criteria for systemic sclerosis: An American College of Rheumatology/ European League against Rheumatism collaborative initiative
    • van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/ European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737-2747
    • (2013) Arthritis Rheum , vol.65 , pp. 2737-2747
    • Vanden Hoogen, F.1    Khanna, D.2    Fransen, J.3    Johnson, S.R.4    Baron, M.5    Tyndall6
  • 17
    • 0027729083 scopus 로고
    • Skin thickness score in systemic sclerosis: An assessment of interobserver variability in 3 independent studies
    • Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993; 20: 1892-1896
    • (1993) J Rheumatol , vol.20 , pp. 1892-1896
    • Clements, P.J.1    Lachenbruch, P.A.2    Seibold, J.R.3    Zee, B.4    Steen, V.D.5    Brennan, P.6
  • 18
    • 0042508746 scopus 로고    scopus 로고
    • European scleroderma study group to define disease activity criteria for systemic sclerosis III assessment of the construct validity of the preliminary activity criteria
    • Valentini G, Bencivelli W, Bombardieri S, D'Angelo S, Della Rossa A, Silman AJ et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 2003; 62: 901-903
    • (2003) Ann Rheum Dis , vol.62 , pp. 901-903
    • Valentini, G.1    Bencivelli, W.2    Bombardieri, S.3    D'Angelo, S.4    Della Rossa, A.5    Silman, A.J.6
  • 19
    • 0038799774 scopus 로고    scopus 로고
    • Natural history of systemic sclerosis and the assessment of severity, functional state, and phychologic well-being
    • Medsger TA. Natural history of systemic sclerosis and the assessment of severity, functional state, and phychologic well-being. Rheum Dis Clin North Am 2003; 29: 255-273
    • (2003) Rheum Dis Clin North Am , vol.29 , pp. 255-273
    • Medsger, T.A.1
  • 20
    • 84949292966 scopus 로고    scopus 로고
    • Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?
    • Oliveira MC, Labopin M, Henes J, Moore J, Papa ND, Cras et al. Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? Bone Marrow Transplant 2016; 51: 501-505
    • (2016) Bone Marrow Transplant , vol.51 , pp. 501-505
    • Oliveira, M.C.1    Labopin, M.2    Henes, J.3    Moore, J.4    Papa, N.D.5    Cras6
  • 21
    • 78650663333 scopus 로고    scopus 로고
    • Skin thickness progression rate: A predictor of mortality and early internal organ involvement in diffuse scleroderma
    • Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger TA Jr. Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis 2011; 70: 104-109
    • (2011) Ann Rheum Dis , vol.70 , pp. 104-109
    • Domsic, R.T.1    Rodriguez-Reyna, T.2    Lucas, M.3    Fertig, N.4    Medsger, T.A.5
  • 22
    • 84932632017 scopus 로고    scopus 로고
    • Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database
    • Maurer B, Graf N, Michel BA, Müller-Ladner U, Czirják L, Denton CP et al. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database. Ann Rheum Dis 2015; 74: 1124-1131
    • (2015) Ann Rheum Dis , vol.74 , pp. 1124-1131
    • Maurer, B.1    Graf, N.2    Michel, B.A.3    Müller-Ladner, U.4    Czirják, L.5    Denton, C.P.6
  • 23
    • 84875725309 scopus 로고    scopus 로고
    • Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: A retrospective analysis
    • Burt RK, Oliveira MC, Shah SJ, Moraes DA, Simoes B, Gheorghiade M et al. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis. Lancet 2013; 381: 1116-1124
    • (2013) Lancet , vol.381 , pp. 1116-1124
    • Burt, R.K.1    Oliveira, M.C.2    Shah, S.J.3    Moraes, D.A.4    Simoes, B.5    Gheorghiade, M.6
  • 24
    • 84983134063 scopus 로고    scopus 로고
    • Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis
    • van Laar JM, Naraghi K, Tyndall A. Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis. Rheumatology 2015; 54: 2126-2133
    • (2015) Rheumatology , vol.54 , pp. 2126-2133
    • Van Laar, J.M.1    Naraghi, K.2    Tyndall, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.